Jan 12
|
Pharma Stock Roundup: MRK to Buy Harpoon, JNJ to Acquire Ambrx Biopharma & More
|
Jan 11
|
AbbVie Inc's Dividend Analysis
|
Jan 11
|
Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition
|
Jan 11
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
Jan 11
|
2 Ultrareliable Dividend Stocks to Buy in 2024 and Hold for at Least a Decade
|
Jan 10
|
UPDATE 2-AbbVie expects Botox to maintain market share as competition heats up
|
Jan 10
|
AbbVie expects Botox to maintain market share as competition heats up
|
Jan 9
|
AbbVie (ABBV) Ascends While Market Falls: Some Facts to Note
|
Jan 9
|
AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
|
Jan 9
|
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union
|
Jan 2
|
2 Biotech Stocks You Can Buy and Hold for the Next Decade
|
Jan 2
|
AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
Jan 2
|
3 Top Dividend Growth Stocks to Buy in 2024
|
Jan 1
|
Here's How Much a $1000 Investment in AbbVie Made 10 Years Ago Would Be Worth Today
|
Dec 31
|
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
|
Dec 31
|
4 Incredible Dividend Stocks Yielding 4%-Plus to Buy in 2024
|
Dec 30
|
These are the largest publicly-traded companies in each US state
|
Dec 29
|
Insider Sell: EVP Nicholas Donoghoe Sells Shares of AbbVie Inc
|
Dec 29
|
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
|
Dec 29
|
11 Best Psychedelic Stocks to Buy in 2024
|